Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
Tong Ren Tang Technologies Co (FRA:TNG) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Tong Ren Tang Technologies Co 14-Day RSI Related Terms
FRA:TNG vs LLY, JNJ, ABBV: 14-Day RSI Comparison
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co 14-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's 14-Day RSI falls into.
Tong Ren Tang Technologies Co (FRA:TNG) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co (FRA:TNG) has a 14-Day RSI of 40.99 as of Aug. 15, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Tong Ren Tang Technologies Co and its competitors. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #167 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 16%.
Is Tong Ren Tang Technologies Co's 14-Day RSI too high?
Tong Ren Tang Technologies Co's current 14-Day RSI is 40.99. The Drug Manufacturers industry median 14-Day RSI is 53.04. Tong Ren Tang Technologies Co's value of 40.99 is 22.7% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #167 out of 1047 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's 14-Day RSI compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #167 out of 1047 companies for 14-Day RSI. This places Tong Ren Tang Technologies Co in the top 16% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 53.04. Tong Ren Tang Technologies Co's value of 40.99 is 22.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 53.04, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current 14-Day RSI of 40.99 is 22.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 53.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current 14-Day RSI is 40.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Tong Ren Tang Technologies Co (FRA:TNG) has a current 14-Day RSI of 40.99. The stock's GF Value™ is €0.56, compared to a current price of €0.32 — trading 43.6% below its estimated fair value. The current 14-Day RSI is 40.99 and 22.7% below the Drug Manufacturers industry median of 53.04. Tong Ren Tang Technologies Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (FRA:TNG), the current 14-Day RSI is 40.99 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (FRA:TNG) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of €0.32 is trading 43.6% below its estimated GF Value™ of €0.56.
Key valuation signals for FRA:TNG:
14-Day RSI: 40.99
GF Value™: €0.56 vs. price of €0.32 (43.6% below fair value)
Industry Position: 22.7% below the Drug Manufacturers median (#167 of 1047)
No single metric tells the full story. See the FRA:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
78GF Score
Get the complete analysis for FRA:TNG
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TNG has been successfully added to your 
